Yuanyuan Duan

机构：Tsinghua University · ORCID：0000-0003-1611-1840

发表论文 40 篇 · 总被引 767 次 · h-index 13

代表论文

• Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2): a randomised, double-blind, placebo-controlled, phase 3 trial (2022 · The Lancet · 被引 139)
• Upadacitinib in patients with psoriatic arthritis and an inadequate response to non-biological therapy: 56-week data from the phase 3 SELECT-PsA 1 study (2021 · RMD Open · 被引 86)
• Efficacy and Safety of Traditional Chinese Medicine in Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis (2021 · Frontiers in Pharmacology · 被引 57)
• Upadacitinib in active ankylosing spondylitis: results of the 2-year, double-blind, placebo-controlled SELECT-AXIS 1 study and open-label extension (2022 · RMD Open · 被引 49)
• Efficacy and Safety of Upadacitinib in Patients with Psoriatic Arthritis: 2-Year Results from the Phase 3 SELECT-PsA 1 Study (2022 · Rheumatology and Therapy · 被引 44)
• Spectrum-Effect Relationship Analysis of Bioactive Compounds in Zanthoxylum nitidum (Roxb.) DC. by Ultra-High Performance Liquid Chromatography Mass Spectrometry Coupled With Comprehensive Filtering Approaches (2022 · Frontiers in Pharmacology · 被引 24)